This inventor holds 1 USPTO granted patent. Top assignees: Genome Pharmaceuticals Institute Co., Ltd., The University of Tokyo. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Kazuhisa Murakami: Innovator in Antibiotic Development
Introduction
Kazuhisa Murakami is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of antibiotic development, particularly through his innovative research on cyclic peptide compounds.
Latest Patents
Murakami holds a patent for a cyclic peptide compound, which includes a method for producing the compound, an anti-infective agent, and an antibiotic-containing fraction. His invention provides a novel compound with a structure distinct from existing drugs, along with a microorganism capable of producing this compound. This innovation is particularly noteworthy for its effectiveness against multiple-drug-resistant bacteria. The patent outlines a cyclic peptide compound or a pharmaceutically acceptable salt thereof, along with a microorganism with Accession No. NITE BP-870 or its naturally or artificially mutated variants.
Career Highlights
Throughout his career, Kazuhisa Murakami has worked with notable organizations, including Genome Pharmaceuticals Institute Co., Ltd. and The University of Tokyo. His work has focused on developing new therapeutic agents that can address the growing challenge of antibiotic resistance.
Collaborations
Murakami has collaborated with esteemed colleagues such as Kazuhisa Sekimizu and Hiroshi Hamamoto, contributing to advancements in the field of microbiology and antibiotic research.
Conclusion
Kazuhisa Murakami's innovative work in antibiotic development highlights the importance of research in combating drug-resistant infections. His contributions continue to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile